Liquidia Technologies

$5.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-3.00%) As of 1:14 PM EDT today
-$0.17 (-3.00%) Today

Why Robinhood?

You can buy or sell LQDA and other stocks, options, ETFs, and crypto commission-free!

About LQDA

Liquidia Technologies, Inc. Common Stock, also called Liquidia Technologies, is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. Read More It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.

Employees
63
Headquarters
Morrisville, North Carolina
Founded
2004
Market Cap
105.52M
Price-Earnings Ratio
Dividend Yield
Average Volume
123.52K
High Today
$5.70
Low Today
$5.26
Open Price
$5.61
Volume
69.78K
52 Week High
$38.46
52 Week Low
$4.94

Collections

LQDA Earnings

-$0.87
-$0.69
-$0.50
-$0.32
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.